New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
February 7, 2013
06:22 EDTGE, CVX, RIG, RDS.ADeep water drilling halted by U.S. over faulty bolts, Bloomberg reports
From the the Gulf of Mexico to Brazil, deep water oil exploration has been disrupted by the discovery of faulty bolts used in safety equipment, reports Bloomberg. Companies such as Chevron (CVX), Royal Dutch Shell (RDS.A) and Transocean (RIG) said they have been directed by U.S. regulators to suspend work aboard rigs that employ GE (GE) devices connecting drilling tubes to safety gear and the seafloor. The equipment must be retrieved so defective bolts can be replaced, said the U.S. Bureau of Safety and Environmental Enforcement. Reference Link
News For A;RIG;GE From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
1 | 2 | 3 | 4 | all recent news | >>
May 18, 2015
11:15 EDTRIGStocks with call strike movement; CHK RIG
Subscribe for More Information
09:36 EDTGEActive equity options trading on open
Subscribe for More Information
08:07 EDTGESplunk appoints Snehal Antani as Chief Technology Officer
Subscribe for More Information
06:56 EDTGEGE, Emerson said to be mulling bids for Aveva, Sunday Times reports
Subscribe for More Information
06:05 EDTGEStocks with implied volatility below IV index mean; MSFT GE
Stocks with implied volatility below IV index mean; Microsoft (MSFT) 17, General Electric (GE) 15 according to iVolatility.
May 15, 2015
18:37 EDTGEGeneral Electric awarded $105M government contract modification
General Electric - Aviation, Cincinnati, Ohio, has been awarded a $105M modification to previously awarded contract FA8650-09-D-2922 to cover the potential award of the Adaptive Engine Technology Development order. This additional research and the resulting data will further mature aircraft engine technologies and decrease risk to achieve a system level preliminary design review and subsequent Adaptive Engine Research Design compatibility review. Work will be performed at Cincinnati, Ohio, and is expected to be complete by Nov. 3, 2016. Funds will be obligated if additional in-scope work is awarded. Air Force Research Laboratory, Wright-Patterson Air Force Base, Ohio, is the contracting activity.
16:31 EDTRIGTransocean declares dividend of 60c per share
Subscribe for More Information
10:45 EDTRIGStocks with call strike movement; CHK RIG
Chesapeake (CHK) October 17 call option implied volatility increased 2% to 45, Transocean (RIG) August 21 call option implied volatility increased 4% to 42 according to IVolatility.
08:08 EDTADarwin Professional presents positive clinical data for ALD403
Alder BioPharmaceuticals announced that six-month follow-up data from its Phase 2 proof-of-concept clinical trial of ALD403, its anti-calcitonin gene-related peptide, or CGRP, antibody for the prevention of frequent episodic migraine, were presented in an oral presentation at the 17th Congress of the International Headache Society in Valencia, Spain. Key Points from Oral Session: Migraine Pathophysiology and CGRP as a Therapeutic Target: A single intravenous dose of ALD403 1000mg demonstrated prolonged efficacy over six months for the preventive treatment of migraine. Over three months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 61% vs 33%; 33% vs 9%; and 16% vs 0%, respectively. Over six months, the proportion of patients with a 50%, 75%, and 100% reduction in migraine days for ALD403 and placebo was 53% vs 28%; 26% vs 7%; and 11% vs 0%, respectively. ALD403 was well tolerated and there were no differences from placebo in terms of adverse events or laboratory safety data. The migraine prevention proof-of-concept trial was conducted in 163 patients with frequent episodic migraine who had on average nine headache days per month. Patients were given a single intravenous dose of 1000mg of ALD403 or placebo. The primary endpoint was the mean change in migraine headache days from baseline to weeks 5-8, and patients were followed for 24 weeks for additional safety and efficacy analyses.
06:03 EDTGEStocks with implied volatility below IV index mean; MSFT GE
Stocks with implied volatility below IV index mean; Microsoft (MSFT) 17, General Electric (GE) 15 according to iVolatility.
05:50 EDTRIGStocks with implied volatility movement; YOKU RIG
Subscribe for More Information
May 13, 2015
12:01 EDTRIGStocks with call strike movement; TWTR RIG
Subscribe for More Information
11:17 EDTGEGE looks to sell Japan commercial finance operation, WSJ says
General Electric is looking to sell its Japanese commercial finance operations, as the conglomerate looks to slim down assets held in its GE Capital unit, says the Wall Street Journal. The unit, which finances the purchase of equipment is valued at about $5B, added the Wall Street Journal. Reference Link
09:39 EDTGEActive equity options trading on open
Subscribe for More Information
08:08 EDTAAgilent volatility elevated into Q1 and sales outlook
Subscribe for More Information
07:08 EDTGEOppenheimer to hold a conference
Subscribe for More Information
06:15 EDTGEEU restart probe of GE's planned acquisition of Alstom's power business, WSJ say
Subscribe for More Information
May 12, 2015
12:13 EDTRIGStocks with call strike movement; AAL RIG
Subscribe for More Information
10:45 EDTGEAnalyst says Pall deal may spark more life sciences M&A
Subscribe for More Information
09:51 EDTGEPall Corp. could be precursor to more Life Science deals, says Janney Capital
After The Wall Street Journal said Pall Corp. (PLL) is nearing a possible sale, naming Thermo Fisher (THO) and Danaher (DHR) as potential suitors, Janney Capital said it thinks dealmaking in the Life Sciences space won't stop with Pall, listing Repligen (RGEN), Bio-Techne (TECH) and VWR (VWR) as others in the industry that could see strategic bids emerge. The firm added that it expects that GE (GE), 3M (MMM), and private equity firms would also be involved in bidding in deals in the space.
1 | 2 | 3 | 4 | all recent news | >>

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use